Please login to the form below

Not currently logged in
Email:
Password:

China

This page shows the latest China news and features for those working in and with pharma, biotech and healthcare.

J&J says COVID-19 vaccine could be ready in early 2021

J&J says COVID-19 vaccine could be ready in early 2021

The vaccine – which has two back-ups – is based on constructs developed after scientists in China released the genetic sequence of the COVID-19 virus in January. ... Meanwhile, academic groups are also advancing candidates, including research teams

Latest news

More from news
Approximately 109 fully matching, plus 558 partially matching documents found.

Latest Intelligence

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    In some areas of India and China, the problem is already endemic and there’s a big pool of MBL-producing bacteria waiting to come our way, initially spread by international

  • China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances

    an interview: “There’s no question there’s very strong expertise in China on automation, roboticisation and miniaturisation. ... Deloitte’s Xiaofeng believes that China’s growth will benefit Europe and the rest of the world.

  • BRIC markets BRIC markets

    Economists started grouping Brazil, Russia, India and China (BRIC) together in the early 2000s based on predicted GDP growth rates. ... And the authors say growth in China could fall to as low as 3% by 2025.

  • 20 for 2020 – Five pharma companies to watch 20 for 2020 – Five pharma companies to watch

    Tagrisso’s growth as it moves earlier in the treatment pathway for EGFR-positive non-small lung cancer (NSCLC) and launches in new markets like China, plus possible label extensions for

  • The changing nature of approvals – what does the future hold? The changing nature of approvals – what does the future hold?

    We will continue to see geographic and therapeutic rebalancing. Growth in sales volume is slowing in the US and Europe, while greater activity has been observed in Mainland China. ... Regulatory processes in Mainland China have become more streamlined,

More from intelligence
Approximately 18 fully matching, plus 116 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 37 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 60 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics